Reny JL - Search Results

1

Antiplatelet therapy: targeting the TxA2 pathway.

Fontana P, Zufferey A, Daali Y, Reny JL. Fontana P, et al. Among authors: reny jl. J Cardiovasc Transl Res. 2014 Feb;7(1):29-38. doi: 10.1007/s12265-013-9529-1. Epub 2013 Dec 19. J Cardiovasc Transl Res. 2014. PMID: 24353037 Review.

2

New antiplatelet strategies in atherothrombosis and their indications.

Fontana P, Reny JL. Fontana P, et al. Among authors: reny jl. Eur J Vasc Endovasc Surg. 2007 Jul;34(1):10-7. doi: 10.1016/j.ejvs.2007.01.004. Epub 2007 Feb 26. Eur J Vasc Endovasc Surg. 2007. PMID: 17324592 Free article.

3

[Antiplatelet agents: which one, when and for whom?].

Reny JL, Zufferey A, Berdagué P, Fontana P. Reny JL, et al. Rev Med Interne. 2010 Dec;31 Suppl 3:S339-41. doi: 10.1016/j.revmed.2010.09.019. Epub 2010 Oct 29. Rev Med Interne. 2010. PMID: 21035923 French. No abstract available.

4

[Pharmacogenetics and antiplatelet drugs].

Fontana P, Reny JL. Fontana P, et al. Among authors: reny jl. Rev Med Interne. 2005 Sep;26(9):725-32. doi: 10.1016/j.revmed.2005.02.006. Epub 2005 Mar 17. Rev Med Interne. 2005. PMID: 16154027 Review. French.

5

Clinical predictors of dual aspirin and clopidogrel poor responsiveness in stable cardiovascular patients from the ADRIE study.

Fontana P, Berdagué P, Castelli C, Nolli S, Barazer I, Fabbro-Peray P, Schved JF, Bounameaux H, Mach F, DE Moerloose P, Reny JL. Fontana P, et al. Among authors: reny jl. J Thromb Haemost. 2010 Dec;8(12):2614-23. doi: 10.1111/j.1538-7836.2010.04063.x. J Thromb Haemost. 2010. PMID: 20860677 Free article.

6

Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysis.

Reny JL, Combescure C, Daali Y, Fontana P; PON1 Meta-Analysis Group. Reny JL, et al. J Thromb Haemost. 2012 Jul;10(7):1242-51. doi: 10.1111/j.1538-7836.2012.04756.x. J Thromb Haemost. 2012. PMID: 22520065 Free PMC article. Review.

7

The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitro.

Ancrenaz V, Desmeules J, James R, Fontana P, Reny JL, Dayer P, Daali Y. Ancrenaz V, et al. Among authors: reny jl. Br J Pharmacol. 2012 Aug;166(8):2362-70. doi: 10.1111/j.1476-5381.2012.01946.x. Br J Pharmacol. 2012. PMID: 22428615 Free PMC article.

8

Platelet hyperreactivity and dual antiplatelet therapy: can biases be avoided?

Fontana P, de Moerloose P, Reny JL. Fontana P, et al. Among authors: reny jl. J Thromb Haemost. 2009 Feb;7(2):363-4. doi: 10.1111/j.1538-7836.2008.03241.x. Epub 2008 Nov 25. J Thromb Haemost. 2009. PMID: 19036060 Free article. No abstract available.

9

Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis.

Reny JL, De Moerloose P, Dauzat M, Fontana P. Reny JL, et al. J Thromb Haemost. 2008 Mar;6(3):444-50. doi: 10.1111/j.1538-7836.2008.02897.x. Epub 2008 Jan 10. J Thromb Haemost. 2008. PMID: 18194417 Free article. Review.

10

[The concept of aspirin "resistance": mechanisms and clinical relevance].

Reny JL, Bonvini RF, Barazer I, Berdagué P, de Moerloose P, Schved JF, Gris JC, Fontana P. Reny JL, et al. Rev Med Interne. 2009 Dec;30(12):1020-9. doi: 10.1016/j.revmed.2009.02.028. Rev Med Interne. 2009. PMID: 19595490 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

198 results

Search Page

Filters